Citi keeps this biotech stock a top pick after trial clears key efficacy milestone
- Posted on August 18, 2026
- By Investing.com
- 0 Views
- 1 min read
In brief
Generating AI summary…
Citi keeps this biotech stock a top pick after trial clears key efficacy milestone
Citi keeps this biotech stock a top pick after trial clears key efficacy milestone